Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Surface Oncology, Inc. | surf-10k_20191231.htm |
| EX-32.1 - EX-32.1 - Surface Oncology, Inc. | surf-ex321_7.htm |
| EX-31.2 - EX-31.2 - Surface Oncology, Inc. | surf-ex312_8.htm |
| EX-31.1 - EX-31.1 - Surface Oncology, Inc. | surf-ex311_10.htm |
| EX-23.1 - EX-23.1 - Surface Oncology, Inc. | surf-ex231_6.htm |
| EX-10.22 - EX-10.22 - Surface Oncology, Inc. | surf-ex1022_477.htm |
| EX-4.3 - EX-4.3 - Surface Oncology, Inc. | surf-ex43_346.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Surface Oncology, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1). |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2). |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: March 10, 2020 |
|
By: |
/s/ Jessica Fees |
|
|
|
|
Jessica Fees |
|
|
|
|
Senior Vice President, Finance (Principal Financial and Accounting Officer) |